Interobserver agreement in the reporting of colorectal polyp pathology among bowel cancer screening pathologists in Wales

Histopathology

Volumn 62, Issue 6, 2013, Pages 916-924

  Turner, Jeff K ^a   Williams, Geraint T ^b   Morgan, Meleri ^a   Wright, Melissa ^b   Dolwani, Sunil ^a,b  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Agreement; Bowel cancer; Histopathology polyps; Screening

Indexed keywords

ADENOMATOUS POLYP; ARTICLE; BENIGN TUMOR; CANCER SCREENING; CLINICAL ARTICLE; COLORECTAL POLYP; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DYSPLASIA; ENDOSCOPIC MUCOSAL RESECTION; EXCISION; GOLD STANDARD; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERRATER RELIABILITY; INTESTINE CANCER; INTESTINE ENDOSCOPY; INTESTINE VILLUS; PATHOLOGIST; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMA; ADENOMATOUS POLYPS; COLONIC POLYPS; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; HYPERPLASIA; INTESTINAL POLYPS; OBSERVER VARIATION; PATHOLOGY, CLINICAL; WALES;

EID: 84876795388     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12110     Document Type: Article

References (27)

1. Bowel Cancer Research UK. Cancer Statistics: 26 types of cancer: bowel (colorectal cancer) - UK incidence statistics. Available at: http://info.cancerresearchuk.org/cancerstats/types/bowel/incidence (accessed 1 August 2012).
2. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36; 2251-2270.
3. Noffsinger AE. Serrated polyps and colorectal cancer: new pathway to malignancy. Annu. Rev. Pathol. 2009; 4; 343-364.
4. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 1993; 329; 1977-1981.
5. NHS BCS Programme Pathology Group. Reporting lesions in the NHS Bowel Cancer Screening Programme. Guidelines from the Bowel Cancer Screening Programme Pathology Group. NHS BCSP publication no. 1. Sheffield: NHS Cancer Screening Programmes, 2007.
6. Quirke P, Risio M, Lambert R et al. Quality assurance in pathology in colorectal cancer screening and diagnosis - European recommendations. Virchows Arch. 2011; 458; 1-19.
7. GI and BCSP pathology EQA schemes. Available at: http://www.gieqa.org.uk/overview/ (accessed 1 August 2012).
8. Brown LJ, Smeeton NC, Dixon MF. Assessment of dysplasia in colorectal adenomas: an observer variation and morphometric study. J. Clin. Pathol. 1985; 38; 174-179.
9. Jensen P, Krogsgaard MR, Christiansen J et al. Observer variability in the assessment of type and dysplasia of colorectal adenomas, analysed using kappa statistics. Dis. Colon Rectum 1995; 38; 195-198.
10. Cross SS, Betmouni S, Burton JL et al. What levels of agreement can be expected between histopathologists assigning cases to discrete nominal categories? A study of the diagnosis of hyperplastic and adenomatous colorectal polyps. Mod. Pathol. 2000; 13; 941-944.
11. Yoon H, Martin A, Benamouzig R et al. Inter-observer agreement on histological diagnosis of colorectal polyps: the APACC study. Gastroenterol. Clin. Biol. 2002; 26; 220-224.
12. Terry MB, Neugut AI, Bostick RM et al. Reliability in the classification of advanced colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 2002; 11; 660-663.
13. Costantini M, Sciallero S, Giannini A et al. Interobserver agreement in the histologic diagnosis of colorectal polyps: the experience of the multicenter adenoma colorectal study (SMAC). J. Clin. Epidemiol. 2003; 56; 209-214.
14. van Putten PG, Hol L, van Dekken H et al. Interobserver variation in the histological diagnosis of polyps in colorectal cancer screening. Histopathology 2011; 58; 974-981.
15. Foss FA, Milkins S, McGregor AH. Inter-observer variability in the histological assessment of colorectal polyps detected through the NHS Bowel Cancer Screening Programme. Histopathology 2012; 61; 47-52.
16. Fleiss JL. Statistical methods for rates and proportions, 2nd edn. New York: John Wiley, 1981; 38-46.
17. Silcocks PB. Measuring repeatability and validity of histological diagnosis - a brief review with some practical examples. J. Clin. Pathol. 1983; 36; 1269-1275.
18. Efron B. The jackknife, the boostrap, and other resampling plans. CBMS-NSF. Monographs 38. Philadelphia, PA: Society of Industrial and Applied Mathematics, 1982.
19. Glatz K, Pritt B, Glatz D et al. A multinational, internet-based assessment of observer variability in the diagnosis of serrated colorectal polyps. Am. J. Clin. Pathol. 2007; 127; 938-945.
20. Farris AB, Misdraji J, Srivastava A et al. Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am. J. Surg. Pathol. 2008; 32; 30-35.
21. Denis B, Peters C, Chapelain C et al. Diagnostic accuracy of community pathologists in the interpretation of colorectal polyps. Eur. J. Gastroenterol. Hepatol. 2009; 21; 1153-1160.
22. Wong NA, Hunt LP, Novelli MR et al. Observer agreement in the diagnosis of serrated polyps of the large bowel. Histopathology 2009; 55; 63-66.
23. Bustamante-Balen M, Bernet L, Cano R et al. Assessing the reproducibility of the microscopic diagnosis of sessile serrated adenoma of the colon. Rev. Esp. Enferm. Dig. 2009; 101; 258-264.
24. Ensari A, Bilezikci B, Carneiro F et al. Serrated polyps of the colon: how reproducible is their classification? Virchows Arch. 2012; 461; 495-504.
25. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. World Health Organization classification of tumors, vol 2. Lyon: IARC Press, 2000.
26. NHS Cancer Screening Programmes. Adenoma surveillance. BCSP Guidance note no. 1, version 1. Sheffield: NHS Cancer Screening Programmes, 2009.
27. Lieberman DA, Rex DK, Winawer SJ et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Gastroenterology 2012; 143; 844-857.